Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4I0L7
Term | Name | Level | Count |
---|---|---|---|
GO:0010921 | regulation of phosphatase activity | 5 | 11 |
GO:0019220 | regulation of phosphate metabolic process | 6 | 11 |
GO:0019222 | regulation of metabolic process | 3 | 11 |
GO:0031323 | regulation of cellular metabolic process | 4 | 11 |
GO:0031399 | regulation of protein modification process | 6 | 11 |
GO:0035303 | regulation of dephosphorylation | 7 | 11 |
GO:0035304 | regulation of protein dephosphorylation | 7 | 11 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 6 | 11 |
GO:0050789 | regulation of biological process | 2 | 11 |
GO:0050790 | regulation of catalytic activity | 3 | 11 |
GO:0050794 | regulation of cellular process | 3 | 11 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 11 |
GO:0051174 | regulation of phosphorus metabolic process | 5 | 11 |
GO:0051246 | regulation of protein metabolic process | 5 | 11 |
GO:0051336 | regulation of hydrolase activity | 4 | 11 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0065009 | regulation of molecular function | 2 | 11 |
GO:0080090 | regulation of primary metabolic process | 4 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016491 | oxidoreductase activity | 2 | 1 |
GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors | 3 | 1 |
GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor | 4 | 1 |
GO:0070191 | methionine-R-sulfoxide reductase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 386 | 390 | PF00656 | 0.478 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.524 |
CLV_PCSK_PC1ET2_1 | 34 | 36 | PF00082 | 0.524 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.472 |
CLV_PCSK_SKI1_1 | 519 | 523 | PF00082 | 0.643 |
DEG_APCC_DBOX_1 | 266 | 274 | PF00400 | 0.422 |
DEG_SCF_FBW7_1 | 3 | 10 | PF00400 | 0.470 |
DEG_SPOP_SBC_1 | 226 | 230 | PF00917 | 0.692 |
DEG_SPOP_SBC_1 | 234 | 238 | PF00917 | 0.543 |
DOC_CDC14_PxL_1 | 79 | 87 | PF14671 | 0.411 |
DOC_CYCLIN_yCln2_LP_2 | 342 | 348 | PF00134 | 0.331 |
DOC_MAPK_DCC_7 | 467 | 477 | PF00069 | 0.431 |
DOC_MAPK_MEF2A_6 | 136 | 145 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 309 | 316 | PF00069 | 0.395 |
DOC_MAPK_MEF2A_6 | 335 | 344 | PF00069 | 0.450 |
DOC_MAPK_MEF2A_6 | 399 | 407 | PF00069 | 0.456 |
DOC_PP1_RVXF_1 | 359 | 365 | PF00149 | 0.489 |
DOC_PP1_RVXF_1 | 69 | 75 | PF00149 | 0.447 |
DOC_PP2B_LxvP_1 | 197 | 200 | PF13499 | 0.500 |
DOC_PP2B_LxvP_1 | 342 | 345 | PF13499 | 0.287 |
DOC_PP4_FxxP_1 | 60 | 63 | PF00568 | 0.422 |
DOC_PP4_FxxP_1 | 80 | 83 | PF00568 | 0.145 |
DOC_USP7_MATH_1 | 130 | 134 | PF00917 | 0.281 |
DOC_USP7_UBL2_3 | 247 | 251 | PF12436 | 0.571 |
DOC_USP7_UBL2_3 | 357 | 361 | PF12436 | 0.544 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.583 |
DOC_WW_Pin1_4 | 301 | 306 | PF00397 | 0.449 |
DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.415 |
DOC_WW_Pin1_4 | 344 | 349 | PF00397 | 0.416 |
DOC_WW_Pin1_4 | 465 | 470 | PF00397 | 0.548 |
DOC_WW_Pin1_4 | 496 | 501 | PF00397 | 0.436 |
LIG_14-3-3_CanoR_1 | 431 | 441 | PF00244 | 0.530 |
LIG_14-3-3_CanoR_1 | 94 | 102 | PF00244 | 0.360 |
LIG_Actin_WH2_2 | 469 | 484 | PF00022 | 0.403 |
LIG_APCC_ABBA_1 | 212 | 217 | PF00400 | 0.742 |
LIG_APCC_ABBA_1 | 457 | 462 | PF00400 | 0.456 |
LIG_BIR_III_4 | 389 | 393 | PF00653 | 0.478 |
LIG_BRCT_BRCA1_1 | 32 | 36 | PF00533 | 0.506 |
LIG_BRCT_BRCA1_1 | 351 | 355 | PF00533 | 0.478 |
LIG_BRCT_BRCA1_1 | 433 | 437 | PF00533 | 0.552 |
LIG_BRCT_BRCA1_2 | 351 | 357 | PF00533 | 0.478 |
LIG_deltaCOP1_diTrp_1 | 310 | 316 | PF00928 | 0.493 |
LIG_deltaCOP1_diTrp_1 | 363 | 370 | PF00928 | 0.466 |
LIG_deltaCOP1_diTrp_1 | 451 | 460 | PF00928 | 0.446 |
LIG_EH1_1 | 315 | 323 | PF00400 | 0.460 |
LIG_FHA_1 | 235 | 241 | PF00498 | 0.537 |
LIG_FHA_1 | 255 | 261 | PF00498 | 0.419 |
LIG_FHA_1 | 298 | 304 | PF00498 | 0.370 |
LIG_FHA_1 | 423 | 429 | PF00498 | 0.522 |
LIG_FHA_1 | 506 | 512 | PF00498 | 0.378 |
LIG_FHA_2 | 107 | 113 | PF00498 | 0.331 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.227 |
LIG_FHA_2 | 266 | 272 | PF00498 | 0.411 |
LIG_FHA_2 | 273 | 279 | PF00498 | 0.381 |
LIG_FXI_DFP_1 | 182 | 186 | PF00024 | 0.393 |
LIG_FXI_DFP_1 | 408 | 412 | PF00024 | 0.278 |
LIG_IRF3_LxIS_1 | 282 | 289 | PF10401 | 0.441 |
LIG_LIR_Gen_1 | 16 | 25 | PF02991 | 0.303 |
LIG_LIR_Gen_1 | 310 | 321 | PF02991 | 0.471 |
LIG_LIR_Gen_1 | 347 | 358 | PF02991 | 0.464 |
LIG_LIR_Gen_1 | 410 | 418 | PF02991 | 0.478 |
LIG_LIR_Gen_1 | 435 | 445 | PF02991 | 0.466 |
LIG_LIR_LC3C_4 | 115 | 119 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 16 | 21 | PF02991 | 0.299 |
LIG_LIR_Nem_3 | 310 | 316 | PF02991 | 0.485 |
LIG_LIR_Nem_3 | 331 | 337 | PF02991 | 0.462 |
LIG_LIR_Nem_3 | 347 | 353 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 434 | 440 | PF02991 | 0.444 |
LIG_MLH1_MIPbox_1 | 434 | 438 | PF16413 | 0.446 |
LIG_Pex14_1 | 366 | 370 | PF04695 | 0.431 |
LIG_Pex14_1 | 74 | 78 | PF04695 | 0.266 |
LIG_Pex14_2 | 407 | 411 | PF04695 | 0.456 |
LIG_Pex14_2 | 437 | 441 | PF04695 | 0.456 |
LIG_REV1ctd_RIR_1 | 243 | 251 | PF16727 | 0.549 |
LIG_SH2_CRK | 202 | 206 | PF00017 | 0.622 |
LIG_SH2_STAP1 | 18 | 22 | PF00017 | 0.395 |
LIG_SH2_STAP1 | 202 | 206 | PF00017 | 0.622 |
LIG_SH2_STAT3 | 78 | 81 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.279 |
LIG_SH3_3 | 247 | 253 | PF00018 | 0.446 |
LIG_SH3_3 | 342 | 348 | PF00018 | 0.355 |
LIG_SH3_3 | 378 | 384 | PF00018 | 0.446 |
LIG_SUMO_SIM_anti_2 | 149 | 155 | PF11976 | 0.331 |
LIG_SUMO_SIM_par_1 | 115 | 121 | PF11976 | 0.222 |
LIG_SUMO_SIM_par_1 | 141 | 146 | PF11976 | 0.337 |
LIG_SUMO_SIM_par_1 | 149 | 155 | PF11976 | 0.252 |
LIG_SUMO_SIM_par_1 | 299 | 304 | PF11976 | 0.400 |
LIG_SUMO_SIM_par_1 | 507 | 512 | PF11976 | 0.374 |
LIG_SxIP_EBH_1 | 236 | 247 | PF03271 | 0.580 |
MOD_CK1_1 | 304 | 310 | PF00069 | 0.557 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.385 |
MOD_CK2_1 | 106 | 112 | PF00069 | 0.441 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.335 |
MOD_CK2_1 | 132 | 138 | PF00069 | 0.226 |
MOD_CK2_1 | 272 | 278 | PF00069 | 0.427 |
MOD_CK2_1 | 304 | 310 | PF00069 | 0.530 |
MOD_CK2_1 | 321 | 327 | PF00069 | 0.414 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.329 |
MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.145 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.555 |
MOD_GlcNHglycan | 288 | 291 | PF01048 | 0.451 |
MOD_GlcNHglycan | 323 | 326 | PF01048 | 0.349 |
MOD_GlcNHglycan | 434 | 437 | PF01048 | 0.430 |
MOD_GlcNHglycan | 469 | 472 | PF01048 | 0.468 |
MOD_GlcNHglycan | 503 | 506 | PF01048 | 0.492 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.437 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.309 |
MOD_GSK3_1 | 225 | 232 | PF00069 | 0.736 |
MOD_GSK3_1 | 234 | 241 | PF00069 | 0.558 |
MOD_GSK3_1 | 282 | 289 | PF00069 | 0.481 |
MOD_GSK3_1 | 297 | 304 | PF00069 | 0.392 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.589 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.467 |
MOD_GSK3_1 | 463 | 470 | PF00069 | 0.442 |
MOD_GSK3_1 | 501 | 508 | PF00069 | 0.508 |
MOD_N-GLC_1 | 146 | 151 | PF02516 | 0.411 |
MOD_N-GLC_2 | 369 | 371 | PF02516 | 0.287 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.590 |
MOD_NEK2_1 | 265 | 270 | PF00069 | 0.422 |
MOD_NEK2_1 | 282 | 287 | PF00069 | 0.366 |
MOD_NEK2_1 | 321 | 326 | PF00069 | 0.438 |
MOD_NEK2_1 | 398 | 403 | PF00069 | 0.364 |
MOD_NEK2_1 | 423 | 428 | PF00069 | 0.473 |
MOD_NEK2_1 | 463 | 468 | PF00069 | 0.316 |
MOD_NEK2_2 | 349 | 354 | PF00069 | 0.287 |
MOD_PIKK_1 | 272 | 278 | PF00454 | 0.397 |
MOD_PK_1 | 299 | 305 | PF00069 | 0.360 |
MOD_Plk_1 | 399 | 405 | PF00069 | 0.276 |
MOD_Plk_2-3 | 162 | 168 | PF00069 | 0.210 |
MOD_Plk_4 | 146 | 152 | PF00069 | 0.411 |
MOD_Plk_4 | 333 | 339 | PF00069 | 0.564 |
MOD_Plk_4 | 505 | 511 | PF00069 | 0.433 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.568 |
MOD_ProDKin_1 | 301 | 307 | PF00069 | 0.462 |
MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.409 |
MOD_ProDKin_1 | 344 | 350 | PF00069 | 0.245 |
MOD_ProDKin_1 | 465 | 471 | PF00069 | 0.430 |
MOD_ProDKin_1 | 496 | 502 | PF00069 | 0.433 |
MOD_SUMO_for_1 | 246 | 249 | PF00179 | 0.558 |
MOD_SUMO_rev_2 | 277 | 282 | PF00179 | 0.510 |
MOD_SUMO_rev_2 | 327 | 337 | PF00179 | 0.385 |
MOD_SUMO_rev_2 | 356 | 362 | PF00179 | 0.421 |
MOD_SUMO_rev_2 | 488 | 498 | PF00179 | 0.551 |
TRG_DiLeu_BaEn_1 | 333 | 338 | PF01217 | 0.508 |
TRG_DiLeu_BaEn_1 | 376 | 381 | PF01217 | 0.232 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.318 |
TRG_ENDOCYTIC_2 | 202 | 205 | PF00928 | 0.620 |
TRG_ENDOCYTIC_2 | 408 | 411 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 430 | 433 | PF00928 | 0.331 |
TRG_ER_diArg_1 | 377 | 380 | PF00400 | 0.385 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5N3 | Leptomonas seymouri | 68% | 100% |
A0A0S4JL71 | Bodo saltans | 34% | 100% |
A0A1X0NWX3 | Trypanosomatidae | 45% | 97% |
A0A3S7WY26 | Leishmania donovani | 99% | 100% |
A0A422NJH6 | Trypanosoma rangeli | 45% | 94% |
A4HD30 | Leishmania braziliensis | 83% | 100% |
C9ZNQ7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 91% |
E9AWH8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4QAZ2 | Leishmania major | 95% | 100% |
V5BB88 | Trypanosoma cruzi | 47% | 95% |